These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 24982912)

  • 21. Co-expression profiling of plasma miRNAs and long noncoding RNAs in gastric cancer patients.
    Ghaedi H; Mozaffari MAN; Salehi Z; Ghasemi H; Zadian SS; Alipoor S; Hadianpour S; Alipoor B
    Gene; 2019 Mar; 687():135-142. PubMed ID: 30447342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNAs as promising biomarkers for gastric cancer.
    Wang F; Sun GP; Zou YF; Hao JQ; Zhong F; Ren WJ
    Cancer Biomark; 2012; 11(6):259-67. PubMed ID: 23248184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gastric Juice MicroRNAs as Potential Biomarkers for Screening Gastric Cancer: A Systematic Review.
    Virgilio E; Giarnieri E; Giovagnoli MR; Montagnini M; Proietti A; D'Urso R; Mercantini P; Balducci G; Cavallini M
    Anticancer Res; 2018 Feb; 38(2):613-616. PubMed ID: 29374683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exosomal miRNAs from Peritoneum Lavage Fluid as Potential Prognostic Biomarkers of Peritoneal Metastasis in Gastric Cancer.
    Tokuhisa M; Ichikawa Y; Kosaka N; Ochiya T; Yashiro M; Hirakawa K; Kosaka T; Makino H; Akiyama H; Kunisaki C; Endo I
    PLoS One; 2015; 10(7):e0130472. PubMed ID: 26208314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exosomal miR-1246 in serum as a potential biomarker for early diagnosis of gastric cancer.
    Shi Y; Wang Z; Zhu X; Chen L; Ma Y; Wang J; Yang X; Liu Z
    Int J Clin Oncol; 2020 Jan; 25(1):89-99. PubMed ID: 31506750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A serum exosomal microRNA panel as a potential biomarker test for gastric cancer.
    Wang N; Wang L; Yang Y; Gong L; Xiao B; Liu X
    Biochem Biophys Res Commun; 2017 Nov; 493(3):1322-1328. PubMed ID: 28986250
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating microRNA-203 predicts metastases, early recurrence, and poor prognosis in human gastric cancer.
    Imaoka H; Toiyama Y; Okigami M; Yasuda H; Saigusa S; Ohi M; Tanaka K; Inoue Y; Mohri Y; Kusunoki M
    Gastric Cancer; 2016 Jul; 19(3):744-53. PubMed ID: 26233325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. microRNAs expression profile related with response to preoperative radiochemotherapy in patients with locally advanced gastric cancer.
    Liu X; Cai H; Sheng W; Huang H; Long Z; Wang Y
    BMC Cancer; 2018 Oct; 18(1):1048. PubMed ID: 30373600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The comprehensive upstream transcription and downstream targeting regulation network of miRNAs reveal potential diagnostic roles in gastric cancer.
    Zhang C; Zhang CD; Liang Y; Wu KZ; Pei JP; Dai DQ
    Life Sci; 2020 Jul; 253():117741. PubMed ID: 32360623
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating miR-18a in plasma contributes to cancer detection and monitoring in patients with gastric cancer.
    Tsujiura M; Komatsu S; Ichikawa D; Shiozaki A; Konishi H; Takeshita H; Moriumura R; Nagata H; Kawaguchi T; Hirajima S; Arita T; Fujiwara H; Okamoto K; Otsuji E
    Gastric Cancer; 2015 Apr; 18(2):271-9. PubMed ID: 24626859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miR-215 promotes malignant progression of gastric cancer by targeting RUNX1.
    Li N; Zhang QY; Zou JL; Li ZW; Tian TT; Dong B; Liu XJ; Ge S; Zhu Y; Gao J; Shen L
    Oncotarget; 2016 Jan; 7(4):4817-28. PubMed ID: 26716895
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advances in molecular biomarkers for gastric cancer: miRNAs as emerging novel cancer markers.
    Wu HH; Lin WC; Tsai KW
    Expert Rev Mol Med; 2014 Jan; 16():e1. PubMed ID: 24456939
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extracellular vesicle derived miR-544 downregulates expression of tumor suppressor promyelocytic leukemia zinc finger resulting in increased peritoneal metastasis in gastric cancer.
    Kong W; Liu X; Yin G; Zheng S; Zhu A; Yu P; Shan Y; Ying R; Zhang J
    Aging (Albany NY); 2020 Nov; 12(23):24009-24022. PubMed ID: 33221764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma miR-940 may serve as a novel biomarker for gastric cancer.
    Liu X; Kwong A; Sihoe A; Chu KM
    Tumour Biol; 2016 Mar; 37(3):3589-97. PubMed ID: 26456959
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of functional lncRNAs in gastric cancer by integrative analysis of GEO and TCGA data.
    Zhang X; Zhang W; Jiang Y; Liu K; Ran L; Song F
    J Cell Biochem; 2019 Oct; 120(10):17898-17911. PubMed ID: 31135068
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exosomal transfer of miR-15b-3p enhances tumorigenesis and malignant transformation through the DYNLT1/Caspase-3/Caspase-9 signaling pathway in gastric cancer.
    Wei S; Peng L; Yang J; Sang H; Jin D; Li X; Chen M; Zhang W; Dang Y; Zhang G
    J Exp Clin Cancer Res; 2020 Feb; 39(1):32. PubMed ID: 32039741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Up-Regulation of miR-21, miR-25, miR-93, and miR-106b in Gastric Cancer.
    LArki P; Ahadi A; Zare A; Tarighi S; Zaheri M; Souri M; Zali MR; Ghaedi H; Omrani MD
    Iran Biomed J; 2018 Nov; 22(6):367-73. PubMed ID: 29859516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel Biomarkers of microRNAs in Gastric Cancer: An Overview from Diagnosis to Treatment.
    Mirzajani E; Vahidi S; Norollahi SE; Samadani AA
    Microrna; 2022; 11(1):12-24. PubMed ID: 35319404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
    Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
    World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor Expression of
    Obermannova R; Redova-Lojova M; Vychytilova-Faltejskova P; Grell P; Cho WC; Sachlova M; Svoboda M; Vyzula R; Slaby O
    Anticancer Res; 2018 Jun; 38(6):3719-3724. PubMed ID: 29848733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.